港股異動 | 反壟斷正式開始!阿里巴巴、騰訊控股午後盤中跌超3%
uSMART盈立智投12月14日消息,週一港股午後,阿里巴巴、騰訊控股跌幅擴大,盤中均跌超3%,
此前,阿里巴巴因未依法申報違法實施經營者集中被市場監管總局處以50萬元罰款。
而騰訊主導的虎牙和鬥魚合併亦被監管關注,市場監管總局表示,正在依法審查廣州虎牙科技有限公司與武漢鬥魚魚樂網絡科技有限公司合併等涉及協議控制架構的經營者集中申報案件。在《關於平臺經濟領域的反壟斷指南》徵求意見稿中也有相關規定。之所以多次強調這個問題,不是說在此之前涉及協議控制結構的經營者集中無需申報,而是爲了進一步明確和重申對依法開展經營者集中申報的要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.